This is the subtitle of a study by Rebaudo et al. (2024) that aims to examine how different factors impact individual willingness to provide caregiving. The study is focused on potential caregivers in Germany. Before we get to the statistical analysis, first some background: Informal Caregiving in Germany The article provides a nice summary of…
One Phase 3 test of Auvelity met its main goal in Alzheimer’s agitation while the drug’s other pivotal trial showed numerical improvement that fell short of statistical significance. Axsome Therapeutics aims to offer an alternative to Rexulti, a Lundbeck and Otsuka Pharmaceutical product that is the only FDA-approved Alzheimer’s agitation drug. The post Axsome Aims…
Many of President-elect Donald Trump’s candidates for federal health agencies have promoted policies and goals that put them at odds with one another or with Trump’s choice to run the Department of Health and Human Services, Robert F. Kennedy Jr., setting the stage for internal friction over public health initiatives. The picks hold different views…
This dashboard monitors progress being made to address the HIV/AIDS epidemic in countries where PEPFAR operates. It includes data for 54 countries and tracks progress against 6 different indicators.
When George Lai of Portland, Oregon, took his toddler son to a pediatrician last summer for a checkup, the doctor noticed a little splinter in the child’s palm. “He must have gotten it between the front door and the car,” Lai later recalled, and the child wasn’t complaining. The doctor grabbed a pair of forceps…
As speculation about whether Medicaid cuts will be part of the solution to our national debt problem continues, no one can predict how much the Medicaid rollback will be, or its impact on the one in five Americans who rely on it. The post When Medicaid Cost Cutting Is Simply Cost Shifting appeared first on…
Medical billing errors are common problems that can lead to significant financial losses for healthcare organizations. While most medical billing errors are preventable, outdated systems, complex processes and human errors often result in delayed or denied claims. Faced with ever-increasing overhead costs, workforce challenges and growing volumes of data, healthcare leaders will need to implement…
Evvy has launched a new line of prescription products to relieve vaginal discomfort. The products are available on the company’s website, with prices ranging from $35 to $59. The post Evvy Introduces Treatments for Common Vaginal Symptoms appeared first on MedCity News.
LISTEN: Tens of thousands of people have filed claims for compensation from pharmaceutical companies accused of fueling the opioid crisis. But few have actually gotten a check. On May 28, WAMU’s “Health Hub” featured KFF Health News senior correspondent Aneri Pattani, who explained why some survivors feel like the money isn’t going to the right…
LISTEN: A National Cancer Institute employee says cuts to research funding and a perceived lack of transparency at the agency are threatening the well-being of cancer patients. A spokesperson for the agency says that’s “misleading” — it’s working to make sure money is well spent. The National Cancer Institute, long credited with driving down U.S….